It might be favorable for the tumor to suppress MITF expression with different strategies like increased BRAF activity that leads to MITF degradation, or increased inhibition of MITF transcription due to SOX5 blocking the binding site of SOX10. This evidence concerns the gene BRAF and neoplasm.